Last reviewed · How we verify
NCT04995107
Effectiveness of Electro-Press Needle for Menopause-associated Hot Flashes
NA trial testing Electro Press needle in Hot Flashes in 122 participants. Status unknown.
30 December 2022
Quick facts
| Lead sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 122 |
| Start date | 20 December 2021 |
| Primary completion | 30 December 2022 |
| Estimated completion | 30 June 2023 |
| Sites | 1 location across China |
Drugs / interventions tested
- Electro Press needle
Conditions studied
- Hot Flashes — all drugs for Hot Flashes →
- Acupuncture Therapy — all drugs for Acupuncture Therapy →
- Perimenopausal Disorder — all drugs for Perimenopausal Disorder →
- Postmenopausal Symptoms — all drugs for Postmenopausal Symptoms →
Sponsor
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
Who can join
Adults 40 to 60, female only, with Hot Flashes or Acupuncture Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators plan to conduct the randomized controlled trial to evaluate the effectiveness of electro-press needle (EPN), a novel acupuncture needle combining shallow and gentle insertion with transdermal electrical stimulation, on menopause-associated hot flash in comparison with waiting-list group among women during menopausal transition and postmenopausal periods.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Effectiveness of electro-press needle for menopause-associated hot flashes: Protocol of a randomized controlled trial.
Yu S, He X, Shi H, Chen Y, et al · · 2022 · PMID 35147087 · DOI 10.1097/md.0000000000028597
Verify or expand the search:
- PubMed search for NCT04995107
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Hot Flashes
Currently open trials in the same condition.
- NCT06957691 — Proof-of-Concept Trial to Assess the Efficacy and Safety of Fezolinetant in Improving Vasomotor Symptoms in Men With Pro · Phase 2 · recruiting
- NCT07335224 — Men With Prostate Cancer: Optimizing Wellness by Enhanced Relief From Hot Flashes With Acupuncture · NA · recruiting
- NCT07455812 — A Study in Germany to Learn About the Value of Fezolinetant in Treating Hot Flashes and Night Sweats in Women During Men · active not recruiting
- NCT06716554 — Efficacy and Safety of Shatavari for Treatment of Menopausal Symptoms in Women: A Randomized, Double-blind, Three-arm, P · NA · recruiting
- NCT06440967 — A Study to Confirm if Fezolinetant Helps Reduce Hot Flashes in Women With Breast Cancer Who Are Having Hormone Therapy · Phase 3 · active not recruiting
Other Guang'anmen Hospital of China Academy of Chinese Medical Sciences trials
Trials by the same sponsor.
- NCT07324148 — Acupuncture for Erectile Dysfunction · NA · not yet recruiting
- NCT07183813 — Acupuncture for Anxiety/Depression in Patients With Breast Cancer · NA · not yet recruiting
- NCT07150234 — Effectiveness of Acupuncture for Cervical Spondylotic Radiculopathy · NA · not yet recruiting
- NCT06996210 — Effect of Acupuncture on Chronic Nonspecific Neck Pain and Insomnia · NA · not yet recruiting
- NCT07079072 — Acupuncture for Lung Cancer-Related Fatigue · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04995107 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Guang'anmen Hospital of China Academy of Chinese Medical Sciences
- Last refreshed: 23 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04995107.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing